-
Continuous Subcutaneous Levodopa Prodrug Infusion
… in time spent in the "off" state and time spent with severe dyskinesias. However, to date, such therapies have been … … Partnering Program … United States … California … Dyskinesia … Symptoms & Side Effects … Improving Levodopa …
-
Adaptive Closed Loop Neuromodulation and Neural Signatures of Parkinson’s Disease
… sometimes dangerous and uncomfortable side effects, such as dyskinesia, as well as mood and cognitive impairment. … … Deep Brain Stimulation … Clinical Trial … California … Dyskinesia … Improved Neuromodulation Approaches … Helen …
-
Chronic Directional Deep Brain Stimulation in Parkinson’s Disease
… … Basal Ganglia … Deep Brain Stimulation … Clinical Trial … Dyskinesia … Improved Neuromodulation Approaches … André …
-
Alleviating late motor complications of Parkinson's disease by a continuous dopaminergic treatment with transdermal delivery of L-DOPA Pro-drug
… for the development of late motor complications, such as dyskinesia and on/off fluctuations. Conversely, it has been … … Symptoms & Side Effects … Complications of Treatment … Dyskinesia … Neuropharmacology … Clinical Trial … Maryland … …
-
Gastric-Retentive, Extended-Release Levodopa/Carbidopa Tablets Versus a Reference, Extended-Release Tablet in Parkinson's Disease
… of levodopa should result in a reduction of side effects (dyskinesia: uncontrolled movements when levels are too high) … PD symptoms should have an added benefit of reducing dyskinesia and akinesia that are caused by current levodopa …
-
Evaluation of a Specific DAT Inhibitor in Pre-clinical Models of Parkinson's Disease
… patients. … Symptoms & Side Effects … Sleep Disorders … Dyskinesia … Neuropharmacology … Pennsylvania … United …